Publications

4907 Results

Mental Component score (MCS) from Health-related Quality of Life Predicts Incidence of Dementia in U.S. Males

Authors
X Ding;E Abner;F Schmitt;J Crowley;P Goodman;R Kryscio
Journal / Conference
Journal of Prevention of Alzheimer's Disease 8(2):169-174
Year
2021
Research Committee(s)
Prevention
PMID
PMID33569563
Study Number(s)
S0000A

Improvement initiative to develop and implement a tool for detecting drug-drug interactions during oncology clinical trial enrollment eligibility screening

Authors
LA Marcath;T Coe;F Shakeel;E Reynolds;M Bayuk;S Haas;BG Redman;S-F Wong;DL Hertz
Journal / Conference
Journal of Patient Safety Jan 1;17(1):e28-e34. doi: 10.1097/PTS.0000000000000772; Sep 29. doi: 10.1097/PTS.0000000000000772. Online ahead of print
Year
2021
Research Committee(s)
Multiple sites
PMID
PMID33003175
PMC
PMC7775319

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer

Authors
R Karunamuni;M Huynh-Le;C Fan;W Thompson;R Eeles;Z Kote-Jarai;C Tangen;P Goodman;IM Thompson;O Andreassen;A Dale;T Seibert
Journal / Conference
International Journal of Cancer Jan 1;148(1):99-105. Epub 2020 Sep 24.Sep 15. doi: 10.1002/ijc.33282. Online ahead of print
Year
2021
Research Committee(s)
Cancer Control and Prevention
PMID
PMID32930425
Study Number(s)
S0000, SWOG-9217

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Authors
F Innocenti;A Sibley;S Patil;A Etheridge;C Jiang;F-S Ou;S Denning;G Casey;M Bertagnolli;H McLeod;T Auman;CD Blanke;Y Furukawa;A Venook;M Kubo;H-J Lenz;J Parker;M Ratain;K Owzar
Journal / Conference
Clinical Cancer Research Jan 1;27(1):267-275
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID32958699
PMC
PMC7785628
Study Number(s)
CTSU/C80405

Bortezomib, Lenalidomide, Dexamethasone with or without Elotuzumab for Untreated, High-Risk Myeloma – Primary Analysis of the SWOG-1211 Randomized Phase II Trial

Authors
S Usmani;A Hoering;S Ailawadhi;R Sexton;B Lipe;S Hita;J Valent;M Rosenzweig;J Zonder;M Dhodapkar;N Callander;T Zimmerman;P Voorhees;B Durie;V Rajkumar;P Richardson;R Orlowski
Journal / Conference
Lancet Haematology Jan;8(1):e45-e54. doi: 10.1016/S2352-3026(20)30354-9. Epub 2020 Dec 22
Year
2021
Research Committee(s)
Myeloma
PMID
PMID33357482
Study Number(s)
S1211

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Authors
D Conti;B Darst;EJ Saunders;X Sheng;A Chou;F Schumacher;D Albanes;C Tangen;P Goodman;IM Thompson;EA Klein;A Hsing;R Eeles;Z Kote-Jarai;C Haiman
Journal / Conference
Nature Genetics Jan 4. doi: 10.1038/s41588-020-00748-0. Online ahead of print.
Year
2021
Research Committee(s)
Cancer Control and Prevention
PMID
PMID33398198
Study Number(s)
S0000, SWOG-9217

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer: Final results from the IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration

Authors
T Andre;J Meyerhardt;T Iveson;A Sobrero;T Yoshino;I Souglakos;D Niedzwiecki;M Saunders;R Labianca;T Yamanaka;I Boukovinas;D Vernerey;J Meyers;A Harkin;V Torri;E Georgoulias;E Oki;J Taieb;AF Shields;Q Shi
Journal / Conference
Lancet Oncology 2020 Dec;21(12):1620-1629. doi: 10.1016/S1470-2045(20)30527-1.
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID33271092
PMC
PMC7786835
Study Number(s)
CTSU/C80702

Alliance trial A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas

Authors
M Katz;Q Shi;J Meyers;J Herman;M Chuong;B Wolpin;S Ahmad;R Marsh;L Schwartz;S Behr;W Frankel;E Collisson;J Leenstra;A Venook;J Meyerhardt;E O'Reilly
Journal / Conference
J Clin Oncol 39, 2021 (suppl 3; abstr 419); ASCO GI Cancers Symposium (January 15-17, 2021, virtual)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021501

Immunologic Predictors of Therapeutic Response to Neoadjuvant Therapy for Pancreatic Adenocarcinoma (PDA) in SWOG S1505

Authors
D Sohal;M Duong;R Chang;Y Xue;D Delman;I Garrido-Laguna;S Mulvihill;K Affolter;MK Washington;MS Beg;A Wang-Gillam;J Wade;N Gandhi;S Ahmad;A Lowy;EG Chiroean;K Guthrie;H Hochster;PA Philip;G Beatty
Journal / Conference
J Clin Oncol 39, 2021 (suppl 3; abstr 419); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), Poster Presentation and Poster Highlights session
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

S2001: Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations

Authors
V Chung;K Guthrie;M Pishvaian;X Yu;A Lowy;EG Chiorean;M Duong;E O'Reilly;PA Philip
Journal / Conference
J Clin Oncol 39, 2021 (suppl 3; abstr TPS447); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), poster session
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
S2001